AXL-L
|
RCC
|
AXL-L
|
RCC
|
cabozantinib tablet Sensitive: B - Late Trials
|
cabozantinib tablet Sensitive: B - Late Trials
|
AXL-L
|
HER2 Positive Breast Cancer
|
AXL-L
|
HER2 Positive Breast Cancer
|
trastuzumab + TP-0903 Sensitive: C3 – Early Trials
|
trastuzumab + TP-0903 Sensitive: C3 – Early Trials
|